RSS

HEMP Hemp, Inc.

Mod: StanleyK
Last Post: 09/30/23
Followers: 82
Posts Today: 0
Views Today: 5143

HEMP Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Nov 10, 3:22 PM EST
Last0.0000
$ Chg0.0000
Open0.0000
High0.0000
Beta7.9076
Year High0.000
Market Cap23.7K
P/B Ratio—
EPS0.00
Avg Vol (30d)1.85M
Volume1.48M
% Chg+0.00%
Prev Close0.0000
Low0.0000
VWAP0.00000
Year Low0.000
Total Shares23.74B
Shares Out23.74B
Float23.74B
ExchangeOTCID
Healthcare Pharmaceuticals

HEMP Stock Message Board Discussion

  1. mountaineer

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

Omni-Lite Industries Reports Impressive Fiscal Q3 Results

Updated Category News Views 143

Highlights from Omni-Lite's Third Quarter Fiscal 2025 Outstanding Financial Performance Omni-Lite Industries Canada Inc. (TSXV: OML) recently reported its financial results for the third quarter of fiscal 2025, demonstrating notable growth and resilience. With revenue reaching approximately US$4.0 million, Omni-Lite saw a remarkable year-over-year increase of 7.0%...

Continue Reading
Assessing the Impact of UK Fiscal Policy on Housing Market Trends

Updated Category News Views 200

Understanding the Current UK Housing Market Dynamics The U.K. housing market is currently facing a notable slowdown, primarily driven by tax-related uncertainties associated with fiscal policies. As potential buyers adopt a more cautious stance, residential property transactions have seen a decline. This trend poses immediate risks for sectors linked to housing, including...

Continue Reading
Radford Racing School Unveils New Exciting Driving Adventures

Updated Category News Views 226

Exciting New Driving Experiences at Radford Racing School Recently, Radford Racing School, known as a leader in performance driving education, announced its latest offerings that promise to thrill automotive enthusiasts of all ages and skill levels. With the introduction of six new driving experiences, there's now something for everyone at their legendary racetrack....

Continue Reading
AppLovin CEO Sells $21.5 Million in Shares Amid Growth Momentum

Updated Category News Views 137

AppLovin CEO's Notable Stock Sale Recently, AppLovin Corp (NASDAQ: APP) made headlines with a significant financial event: CEO and Chairperson Arash Adam Foroughi sold over $21.5 million worth of company stock. According to the latest SEC filing, this noteworthy transaction occurred over just two days, with share prices varying from $98.08 to $112.33 during that time....

Continue Reading
Olverembatinib's Breakthrough Status Enhances Leukemia Treatment Options

Updated Category News Views 396

Olverembatinib Gains Breakthrough Therapy Designation Ascentage Pharma, a prominent global biopharmaceutical company, is making significant strides in the treatment of serious medical conditions. With its latest achievement, olverembatinib has secured a Breakthrough Therapy Designation in China for its use alongside low-intensity chemotherapy in newly-diagnosed patients...

Continue Reading